{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:16:19Z","timestamp":1781486179138,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2258,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/ki.2009.269","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T12:39:22Z","timestamp":1248871162000},"page":"877-884","source":"Crossref","is-referenced-by-count":47,"title":["Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients"],"prefix":"10.1016","volume":"76","author":[{"given":"Stefan","family":"Farese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte M.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik E.","family":"Uehlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix J.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.269_bb0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1525-139X.2001.00087.x","article-title":"Hyperkalemia in dialysis patients","volume":"14","author":"Ahmed","year":"2001","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2009.269_bb0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000167443","article-title":"Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis","volume":"7","author":"Tzamaloukas","year":"1987","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2009.269_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/cs0730247","article-title":"Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis","volume":"73","author":"Sandle","year":"1987","journal-title":"Clin Sci (London)"},{"key":"10.1038\/ki.2009.269_bb0025","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.ajkd.2006.01.014","article-title":"A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients","volume":"47","author":"Kaisar","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.269_bb0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(86)80120-2","article-title":"Increased secretion of potassium in the rectum of humans with chronic renal failure","volume":"8","author":"Martin","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.269_bb0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0272-6386(12)80663-9","article-title":"Use of sodium polystyrene sulfonate in sorbitol in the United States, 1985-1989","volume":"18","author":"Gerstman","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.269_bb0040","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.V9101924","article-title":"Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease","volume":"9","author":"Gruy-Kapral","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.269_bb0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-200105000-00011","article-title":"Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings","volume":"25","author":"Abraham","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/ki.2009.269_bb0050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(66)90697-0","article-title":"Dangers of resonium A in the treatment of hyperkalemia in renal failure","volume":"1","author":"Berlyne","year":"1966","journal-title":"Lancet"},{"key":"10.1038\/ki.2009.269_bb0055","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1172\/JCI114380","article-title":"Regulation of active sodium and potassium transport in the distal colon of the rat. Role of the aldosterone and glucocorticoid receptors","volume":"84","author":"Turnamian","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.269_bb0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/gut.16.4.277","article-title":"Electrical potential difference, sodium absorption and potassium secretion by the human rectum during carbenoxolone therapy","volume":"16","author":"Tomkins","year":"1975","journal-title":"Gut"},{"key":"10.1038\/ki.2009.269_bb0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/cs0710393","article-title":"Enhanced rectal potassium secretion in chronic renal insufficiency: evidence for large intestinal potassium adaptation in man","volume":"71","author":"Sandle","year":"1986","journal-title":"Clin Sci (London)"},{"key":"10.1038\/ki.2009.269_bb0070","first-page":"G42","article-title":"Enzyme- and mineralocorticoid receptor-controlled electrogenic Na+ absorption in human rectum in vitro","volume":"269","author":"Epple","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2009.269_bb0075","doi-asserted-by":"crossref","first-page":"28762","DOI":"10.1074\/jbc.274.40.28762","article-title":"The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane","volume":"274","author":"Odermatt","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2009.269_bb0080","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","article-title":"Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme","volume":"105","author":"Albiston","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"10.1038\/ki.2009.269_bb0085","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1038\/ki.2009.269_bb0090","first-page":"135","article-title":"11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess","volume":"18","author":"White","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1038\/ki.2009.269_bb0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.mnh.0000133976.32559.b0","article-title":"Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension","volume":"13","author":"Frey","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2009.269_bb0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1681\/ASN.V131191","article-title":"Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria","volume":"13","author":"Serra","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.269_bb0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1172\/JCI106809","article-title":"Pathophysiology of intense physical conditioning in a hot climate. I. Mechanisms of potassium depletion","volume":"51","author":"Knochel","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.269_bb0110","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/hy1101.096112","article-title":"In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice","volume":"38","author":"Ferrari","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.269_bb0115","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1681\/ASN.2006111235","article-title":"Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess","volume":"18","author":"Atanasov","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.269_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000168604","article-title":"Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease","volume":"13","author":"Singhal","year":"1993","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2009.269_bb0125","doi-asserted-by":"crossref","first-page":"F843","DOI":"10.1152\/ajprenal.00110.2003","article-title":"Regulation of NHE3, NKCC2, and NCC abundance in kidney during aldosterone escape phenomenon: role of NO","volume":"285","author":"Turban","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2009.269_bb0130","first-page":"283","article-title":"Aldosterone Stimulation in Vitro. I. Evaluation of Assay Procedure and Determination of Aldosterone-Stimulating Activity in a Human Urine Extract","volume":"48","author":"Mueller","year":"1965","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1038\/ki.2009.269_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/jcem-41-1-153","article-title":"Potassim-aldosterone-renin interrelationships","volume":"41","author":"Himathongkam","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2009.269_bb0140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.269_bb0145","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.269_bb0150","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1210\/en.2006-0826","article-title":"Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects","volume":"147","author":"Funder","year":"2006","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.269_bb0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure","volume":"93","author":"Qin","year":"2003","journal-title":"Circ Res"},{"key":"10.1038\/ki.2009.269_bb0160","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1042\/CS20080247","article-title":"Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart","volume":"116","author":"Wilson","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/ki.2009.269_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbamem.2007.10.008","article-title":"Glycyrrhetinic acid as inhibitor or amplifier of permeability transition in rat heart mitochondria","volume":"1778","author":"Battaglia","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/ki.2009.269_bb0170","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/hep.22239","article-title":"Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways","volume":"47","author":"Wu","year":"2008","journal-title":"Hepatology"},{"key":"10.1038\/ki.2009.269_bb0175","first-page":"295","article-title":"11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome","volume":"9","author":"Schnackenberg","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1038\/ki.2009.269_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.186.2.189","article-title":"Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone\/cortisol shuttle","volume":"186","author":"Escher","year":"1997","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2009.269_bb0185","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20050119","article-title":"11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice","volume":"202","author":"Hermanowski-Vosatka","year":"2005","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2009.269_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endo.135.1.8013341","article-title":"11 beta-Hydroxysteroid dehydrogenase accounts for low prednisolone\/prednisone ratios in the kidney","volume":"135","author":"Escher","year":"1994","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.269_bb0195","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000064116","article-title":"Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis","volume":"92","author":"Furuya","year":"2002","journal-title":"Nephron"},{"key":"10.1038\/ki.2009.269_bb0200","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/ndt\/gfm386","article-title":"Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis","volume":"22","author":"Kim","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.269_bb0205","first-page":"1","article-title":"Exogenous mineralocorticoid hormone improves predialysis hyperkalemia in anephric man","volume":"8","author":"Whalen","year":"1978","journal-title":"Proc Clin Dial Transplant Forum"},{"key":"10.1038\/ki.2009.269_bb0210","series-title":"Goodmans & Gilman's \u201cThe Pharmalogical Basis of Therapeutics\u201d","first-page":"1594","article-title":"Hormones and hormone antagonists","author":"Parker","year":"2006"},{"issue":"Suppl","key":"10.1038\/ki.2009.269_bb0215","first-page":"1133","article-title":"[Pharmacokinetics of 9 -fluorhydrocortisone]","volume":"21","author":"Vogt","year":"1971","journal-title":"Arzneimittelforschung"},{"key":"10.1038\/ki.2009.269_bb0220","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1074\/jbc.M111549200","article-title":"In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3","volume":"277","author":"Nawrocki","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2009.269_bb0225","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1172\/JCI21647","article-title":"Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression","volume":"114","author":"Alikhani-Koopaei","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.269_bb0230","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1096\/fj.07-8140com","article-title":"Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity","volume":"21","author":"Alikhani-Koupaei","year":"2007","journal-title":"FASEB J"},{"key":"10.1038\/ki.2009.269_bb0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1681\/ASN.2007030263","article-title":"DHEA induces 11 -HSD2 by acting on CCAAT\/enhancer-binding proteins","volume":"19","author":"Balazs","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.269_bb0240","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1440-1746.1999.02008.x","article-title":"Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I\/II trial","volume":"14","author":"van Rossum","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1038\/ki.2009.269_bb0245","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/S0002-9270(01)02612-0","article-title":"Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C","volume":"96","author":"van Rossum","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/ki.2009.269_bb0250","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1172\/JCI12745","article-title":"Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis","volume":"108","author":"Quattropani","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.269_bb0255","first-page":"811","article-title":"Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome","volume":"84","author":"Vogt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2009.269_bb0260","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0009-9236(96)90025-9","article-title":"Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid dehydrogenase","volume":"59","author":"Lee","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/ki.2009.269_bb0265","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/endo.139.9.6175","article-title":"Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2","volume":"139","author":"Fuster","year":"1998","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.269_bb0270","doi-asserted-by":"crossref","first-page":"28484","DOI":"10.1074\/jbc.M100374200","article-title":"The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2","volume":"276","author":"Odermatt","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815540660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815540660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T05:08:48Z","timestamp":1633756128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815540660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0085253815540660"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.269","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}